reference : Transmission of West Nile virus through blood transfusion in the United States in 2002

JSON YAML text HTML Turtle N-Triples JSON Triples RDF+XML RDF+JSON Graphviz SVG
/reference/5033e5b6-ca03-448b-9b96-ada0ed7bdaef
Bibliographic fields
reftype Journal Article
Abstract BACKGROUND: During the 2002 West Nile virus epidemic in the United States, patients were identified whose West Nile virus illness was temporally associated with the receipt of transfused blood and blood components. METHODS: Patients with laboratory evidence of recent West Nile virus infection within four weeks after receipt of a blood component from a donor with viremia were considered to have a confirmed transfusion-related infection. We interviewed the donors of these components, asking them whether they had had symptoms compatible with the presence of a viral illness before or after their donation; blood specimens retained from the time of donation and collected at follow-up were tested for West Nile virus. RESULTS: Twenty-three patients were confirmed to have acquired West Nile virus through transfused leukoreduced and nonleukoreduced red cells, platelets, or fresh-frozen plasma. Of the 23 recipients, 10 (43 percent) were immunocompromised owing to transplantation or cancer and 8 (35 percent) were at least 70 years of age. Immunocompromised recipients tended to have longer incubation periods than nonimmunocompromised recipients and infected persons in mosquito-borne community outbreaks. Sixteen donors with evidence of viremia at donation were linked to the 23 infected recipients; of these donors, 9 reported viral symptoms before or after donation, 5 were asymptomatic, and 2 were lost to follow-up. Fever, new rash, and painful eyes were independently associated with being an implicated donor with viremia rather than a donor without viremia. All 16 donors were negative for West Nile virus-specific IgM antibody at donation. CONCLUSIONS: Transfused red cells, platelets, and fresh-frozen plasma can transmit West Nile virus. Screening of potential donors with the use of nucleic acid-based assays for West Nile virus may reduce this risk.
Author Pealer, L. N.; Marfin, A. A.; Petersen, L. R.; Lanciotti, R. S.; Page, P. L.; Stramer, S. L.; Stobierski, M. G.; Signs, K.; Newman, B.; Kapoor, H.; Goodman, J. L.; Chamberland, M. E.
DOI 10.1056/NEJMoa030969
Date Sep 25
ISSN 1533-4406
Issue 13
Journal New England Journal of Medicine
Keywords Adolescent; Adult; Aged; Blood Donors; Blood Transfusion/*adverse effects; Blood-Borne Pathogens/*isolation & purification; Child; Female; Humans; Male; Middle Aged; RNA, Viral/blood; United States/epidemiology; Viremia/diagnosis; West Nile Fever/diagnosis/epidemiology/*transmission; West Nile virus/genetics/*isolation & purification
Notes Pealer, Lisa N Marfin, Anthony A Petersen, Lyle R Lanciotti, Robert S Page, Peter L Stramer, Susan L Stobierski, Mary Grace Signs, Kimberly Newman, Bruce Kapoor, Hema Goodman, Jesse L Chamberland, Mary E eng 2003/09/23 05:00 N Engl J Med. 2003 Sep 25;349(13):1236-45. Epub 2003 Sep 18.
Pages 1236-1245
Title Transmission of West Nile virus through blood transfusion in the United States in 2002
Volume 349
Year 2003
Bibliographic identifiers
.reference_type 0
_record_number 18019
_uuid 5033e5b6-ca03-448b-9b96-ada0ed7bdaef